![](/img/cover-not-exists.png)
RE: Reyes A, Révil C, Niggli M, et al. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Curr Med Res Opin. 2019;35(12):2079â2087
Jain, Nisha, Lethagen, StefanJournal:
Current Medical Research and Opinion
DOI:
10.1080/03007995.2020.1744549
Date:
April, 2020
File:
PDF, 553 KB
2020